Clinical Trial Update: A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the dengue vaccine in healthy toddlers aged 12 to 15 months in the Philippines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• Dengvaxia (CYD-TDV)

Snippet

Sponsor: Sanofi | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | Status: COMPLETED